Ashley Marie Scott, MD, will help discuss the current evidence for and against the administration of different coagulation factors prior to ICU procedures during a panel discussion Wednesday.

A. Christine Argento, MD, FCCP, will chair a groundbreaking session on current evidence and future pathways for intratumoral therapy in lung cancer treatment.

Bonnie Wang, MD, will chair a session focusing on the variable presentations of acute COVID lung disease, post-COVID organizing pneumonia, and post-COVID fibrosis.

Sunita Kumar, MD, FCCP, will chair a discussion on hypoglossal nerve stimulation therapy; the use of oral appliances; the developing potential for pharmacotherapy; and the utility of weight loss, position therapy, and supplemental oxygen in the treatment of OSA.

This year, the CHEST Foundation awarded more than $600,000 in clinical research and community service grants to 23 individuals.

On Monday, October 17, Christine Won, MD, MSc, and two other sleep medicine experts discussed alternative therapies for patients with obesity hypoventilation for whom positive airway pressure therapy fails.

Steven Hollenberg, MD, FCCP, helped present an interactive session Monday, October 17, that gave audience members a chance to collectively discuss and weigh in on appropriate treatment options for three case studies.

A panel discussion Tuesday afternoon will explore how conversations around lung transplantation are changing, allowing for nuanced discussions of management options and the comparative risks of transplanting vs rejecting donor organs.

Daniel Ouellette, MD, MS, FCCP, will chair a session reviewing the latest evidence-based guidance for liberating high-risk ICU patients from mechanical ventilation.

Simon Mucha, MD, will chair a discussion on how a multidisciplinary team in a dedicated liver ICU has improved outcomes by applying emerging strategies for monitoring and treatment.